
Sign up to save your podcasts
Or
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
4.9
1212 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
138 Listeners
37 Listeners
323 Listeners
101 Listeners
500 Listeners
700 Listeners
38 Listeners
290 Listeners
3,333 Listeners
17 Listeners
18 Listeners
13 Listeners
6 Listeners
88 Listeners
1,139 Listeners
30 Listeners
190 Listeners
514 Listeners
368 Listeners
430 Listeners
19 Listeners
373 Listeners
54 Listeners